标题
Successes, failures, and future prospects of prodrugs and their clinical impact
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 14, Issue 3, Pages 199-220
出版商
Informa UK Limited
发表日期
2019-02-04
DOI
10.1080/17460441.2019.1567487
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Management of Statin Intolerance in 2018: Still More Questions Than Answers
- (2018) Peter P. Toth et al. American Journal of Cardiovascular Drugs
- Fesoterodine: Pharmacological properties and clinical implications
- (2018) Xavier Gamé et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity
- (2018) J. Denis et al. JOURNAL DE MYCOLOGIE MEDICALE
- Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity
- (2018) M.-P. Ledoux et al. JOURNAL DE MYCOLOGIE MEDICALE
- Strategies for Enhancing the Permeation of CNS-Active Drugs through the Blood-Brain Barrier: A Review
- (2018) Isra’ Zeiadeh et al. MOLECULES
- Fostemsavir
- (2018) Pedro Cahn et al. Current Opinion in HIV and AIDS
- Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas
- (2018) Jun Gong et al. Drug Design Development and Therapy
- An evaluation of tedizolid for the treatment of MRSA infections
- (2018) Ronald G. Hall et al. EXPERT OPINION ON PHARMACOTHERAPY
- The prodrug approach in the era of drug design
- (2018) Anas Najjar et al. Expert Opinion on Drug Delivery
- Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections
- (2017) Darrell McBride et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma
- (2017) Marco Salvini et al. Expert Opinion on Drug Metabolism & Toxicology
- Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
- (2017) William D Tap et al. LANCET ONCOLOGY
- Initiation, Continuation, or Withdrawal of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
- (2017) Lauren G. Gilstrap et al. Journal of the American Heart Association
- Evofosfamide, a new horizon in the treatment of pancreatic cancer
- (2016) Mohsen Pourmorteza et al. ANTI-CANCER DRUGS
- A phase 1 ‘window-of-opportunity’ trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
- (2016) Ruben T. H. M. Larue et al. BMC CANCER
- Telotristat ethyl: a new option for the management of carcinoid syndrome
- (2016) Angela Lamarca et al. EXPERT OPINION ON PHARMACOTHERAPY
- A minireview on N -acetylcysteine: An old drug with new approaches
- (2016) Ines Elbini Dhouib et al. LIFE SCIENCES
- Primary Open-Angle Glaucoma Preferred Practice Pattern® Guidelines
- (2016) Bruce E. Prum et al. OPHTHALMOLOGY
- Cardiovascular Safety Pharmacology of Sibutramine
- (2015) Jaesuk Yun et al. Biomolecules & Therapeutics
- Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel
- (2015) Xi-Ling Jiang et al. CLINICAL PHARMACOKINETICS
- Sacubitril/Valsartan (Entresto) for Heart Failure
- (2015) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects
- (2015) Arianna Mareri et al. Journal of Maternal-Fetal & Neonatal Medicine
- Statin prescription patterns, adherence, and attainment of cholesterol treatment goals in routine clinical care: a Danish population-based study
- (2015) Elisabeth Svensson et al. Clinical Epidemiology
- First-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma
- (2015) Sant P. Chawla et al. JAMA Oncology
- A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma
- (2014) Sant P. Chawla et al. CANCER
- Patterns of Statin Initiation, Intensification, and Maximization Among Patients Hospitalized With an Acute Myocardial Infarction
- (2014) Suzanne V. Arnold et al. CIRCULATION
- Sofosbuvir: A Review of its Use in Patients with Chronic Hepatitis C
- (2014) Gillian M. Keating DRUGS
- Using predrugs to optimize drug candidates
- (2014) Rafik Karaman Expert Opinion on Drug Discovery
- Predicting potential liver toxicity from phase 2 data: a case study with ximelagatran
- (2014) Harry Southworth STATISTICS IN MEDICINE
- Meta-analyses of dose-exposure relationships for gabapentin following oral administration of gabapentin and gabapentin enacarbil
- (2013) Chao Chen EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
- (2013) Kris V Kowdley et al. LANCET
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies
- (2012) Muhammad Baluom et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?
- (2012) Hua Rong Lu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Lisdexamfetamine Dimesylate
- (2012) Christopher Steer et al. CNS DRUGS
- Aripiprazole
- (2012) Jamie D. Croxtall CNS DRUGS
- Interferon-Free Hepatitis C Therapy
- (2012) Paul J. Pockros DRUGS
- Studies on the Metabolism and Biological Activity of the Epimers of Sulindac
- (2011) D. Brunell et al. DRUG METABOLISM AND DISPOSITION
- Aripiprazole
- (2011) Sohita Dhillon DRUGS
- Metabolism of Fostamatinib, the Oral Methylene Phosphate Prodrug of the Spleen Tyrosine Kinase Inhibitor R406 in Humans: Contribution of Hepatic and Gut Bacterial Processes to the Overall Biotransformation
- (2010) D. J. Sweeny et al. DRUG METABOLISM AND DISPOSITION
- Codrug: An efficient approach for drug optimization
- (2010) N. Das et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacokinetic evaluation of fosaprepitant dimeglumine
- (2010) Francheska Colon-Gonzalez et al. Expert Opinion on Drug Metabolism & Toxicology
- Leflunomide: a drug with a potential beyond rheumatology
- (2010) Sven Teschner et al. Immunotherapy
- Pharmacokinetics of Acyclovir and Its Metabolites in Cerebrospinal Fluid and Systemic Circulation after Administration of High-Dose Valacyclovir in Subjects with Normal and Impaired Renal Function
- (2009) J. P. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Balsalazide in treating colonic diseases
- (2009) Antonio Tursi Expert Opinion on Drug Metabolism & Toxicology
- Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs
- (2008) Jian-Xin Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prodrugs in Cardiovascular Therapy
- (2008) Marinella Sandros et al. MOLECULES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation